STING1 and neoplasm: While activation of immune pathways such as STING in the acute phase promotes an antitumourigenic response, in the chronic phase, DNA damage repair-deficient tumours instead exploit this STING-mediated immune response, tailoring it to promote a proinvasive microenvironment favouring tumour growth.